Jenna Tomkinson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jenna Tomkinson has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
- Gregory P. Way
Department of Biomedical Informatics, University of Colorado Anschutz, Aurora, USA
10 shared publications - Dave Bunten
Department of Biomedical Informatics, University of Colorado Anschutz, Aurora, CO 80045, USA
5 shared publications - Michael J. Lippincott
Department of Biomedical Informatics, University of Colorado Anschutz Medical Campus, Aurora, USA
5 shared publications Akiko Nakde
Life Business Headquarters, Yokogawa Electric Corporation
2 shared publicationsCameron Mattson
Department of Biomedical Informatics, University of Colorado Anschutz, Aurora, USA
2 shared publications- Carla Basualto-Alarcón
Centro PUENTES de Investigación en Salud, Departamento de Ciencias de la Salud Universidad de Aysén, Coyhaique Región de Aysén Chile
2 shared publications
Latest Publications
- Top Cited PapersOpen Access
- 27 March 2026
- Published by Springer Nature in Molecular Systems Biology
- Vol. 22 (5) , 624-658
Progress and new challenges in image-based profiling
For over two decades, image-based profiling has revolutionized cell phenotype analysis. Image-based profiling processes rich, high-throughput, microscopy data into thousands of unbiased measurements that reveal phenotypic patterns powerful for drug discovery, functional genomics, and cell state classification. Here, we review the evolving computational landscape of image-based profiling, detailing the bioinformatics processes involved from feature extraction to normalization and batch correction. We discuss how deep learning has fundamentally reshaped the field. We examine key methodological advancements, such as single-cell analysis, the development of robust similarity metrics, and the expansion into new modalities like optical pooled screening, temporal imaging, and 3D organoid profiling. We also highlight the growth of public benchmarks and open-source software ecosystems as a key driver for fostering reproducibility and collaboration. Despite these advances, the field still faces substantial challenges, particularly in developing methods for emerging temporal and 3D data modalities, establishing robust quality control standards and workflows, and interpreting the processed features. By focusing on the technical evolution of image-based profiling rather than the wide-ranging biological applications, our aim with this review is to provide researchers with a roadmap for navigating the progress and new challenges in this rapidly advancing domain.
- 27 March 2026
- Published by Springer Nature in Molecular Systems Biology
- Vol. 22 (5) , 624-658
Top Cited PapersOpen AccessProgress and new challenges in image-based profiling
For over two decades, image-based profiling has revolutionized cell phenotype analysis. Image-based profiling processes rich, high-throughput, microscopy data into thousands of unbiased measurements that reveal phenotypic patterns powerful for drug discovery, functional genomics, and cell state classification. Here, we review the evolving computational landscape of image-based profiling, detailing the bioinformatics processes involved from feature extraction to normalization and batch correction. We discuss how deep learning has fundamentally reshaped the field. We examine key methodological advancements, such as single-cell analysis, the development of robust similarity metrics, and the expansion into new modalities like optical pooled screening, temporal imaging, and 3D organoid profiling. We also highlight the growth of public benchmarks and open-source software ecosystems as a key driver for fostering reproducibility and collaboration. Despite these advances, the field still faces substantial challenges, particularly in developing methods for emerging temporal and 3D data modalities, establishing robust quality control standards and workflows, and interpreting the processed features. By focusing on the technical evolution of image-based profiling rather than the wide-ranging biological applications, our aim with this review is to provide researchers with a roadmap for navigating the progress and new challenges in this rapidly advancing domain.
- 21 January 2026
- Published by EMBL-EBI
High-content live-cell time-lapse imaging predicts cells about to die via apoptosis
BioStudies – one package for all the data supporting a study
- 21 January 2026
- Published by EMBL-EBI
High-content live-cell time-lapse imaging predicts cells about to die via apoptosis
BioStudies – one package for all the data supporting a study
- Open Access
High-content live-cell time-lapse imaging predicts cells about to die via apoptosis
Cell death is a dynamic process that unfolds through time. Live-cell time-lapse imaging captures these dynamics in a way that’s impossible for static snapshots. High-content imaging (HCI), which has been developed for static microscopy, applied to time-lapse imaging can quantify how single-cell states change through time. Here we show the ability of high-content live-cell time-lapse imaging (HCLTI) to quantify the onset and progression of one form of cell death called apoptosis. We apply the Live Cell Painting assay called ChromaLIVE TM and develop an HCLTI analysis pipeline. We show that HCLTI can discern the morphology dynamics of cells undergoing apoptosis, and demonstrate that machine learning can predict apoptosis as early as 100 minutes after exposing HeLa cells to the apoptosis inducer Staurosporine. This technical advancement paves the way for future studies to better understand the dynamics of other forms of cell death. Understanding cell death dynamics is one piece of solving larger biomedical puzzles like understanding how cells resist death (e.g., therapeutic resistance of cancer cells) and how cells die too soon (e.g., neurodegeneration).
Open AccessHigh-content live-cell time-lapse imaging predicts cells about to die via apoptosis
Cell death is a dynamic process that unfolds through time. Live-cell time-lapse imaging captures these dynamics in a way that’s impossible for static snapshots. High-content imaging (HCI), which has been developed for static microscopy, applied to time-lapse imaging can quantify how single-cell states change through time. Here we show the ability of high-content live-cell time-lapse imaging (HCLTI) to quantify the onset and progression of one form of cell death called apoptosis. We apply the Live Cell Painting assay called ChromaLIVE TM and develop an HCLTI analysis pipeline. We show that HCLTI can discern the morphology dynamics of cells undergoing apoptosis, and demonstrate that machine learning can predict apoptosis as early as 100 minutes after exposing HeLa cells to the apoptosis inducer Staurosporine. This technical advancement paves the way for future studies to better understand the dynamics of other forms of cell death. Understanding cell death dynamics is one piece of solving larger biomedical puzzles like understanding how cells resist death (e.g., therapeutic resistance of cancer cells) and how cells die too soon (e.g., neurodegeneration).
- Open Access
Stellar quality control for single-cell image-based profiling with coSMicQC
Over the past twenty years, high-content imaging has transformed our ability to measure cell phenotypes. The need to bioinformatically process these phenotypes led to the development of a research field called image-based profiling. However, because the standard image-based profiling approach involves averaging data, single-cell quality control (QC) has been historically ignored. The conventional approach of aggregating single cells into bulk profiles conserves computational resources and reduces, but does not completely remove, the impact of low-quality single cells. As software improves in processing scalability, researchers increasingly use single-cell image-based profiling to reveal important signals of phenotypic heterogeneity. Therefore, this evolution of image-based profiling toward single cells compels single-cell QC standards to ensure that observed morphology differences are driven by biology and not technical interference. We address these challenges with coSMicQC (Single cell Morphology Quality Control), a reproducible Python package with comprehensive tutorials that supports systematic filtering of low-quality single cells. CoSMicQC integrates seamlessly into standard image-based profiling protocols, providing an interactive, Jupyter-compatible user interface to detect technical outliers and set automatic thresholds. We applied coSMicQC to multiple real-world datasets and showed that our software improves data quality, detects mycoplasma contamination, and boosts phenotype prediction. When applied to a large-scale drug screening dataset, coSMicQC rescued lead compounds that would have been missed. Overall, coSMicQC is a reliable and scalable method that removes technical outliers to reduce noise and improve image-based profiling insights.
Open AccessStellar quality control for single-cell image-based profiling with coSMicQC
Over the past twenty years, high-content imaging has transformed our ability to measure cell phenotypes. The need to bioinformatically process these phenotypes led to the development of a research field called image-based profiling. However, because the standard image-based profiling approach involves averaging data, single-cell quality control (QC) has been historically ignored. The conventional approach of aggregating single cells into bulk profiles conserves computational resources and reduces, but does not completely remove, the impact of low-quality single cells. As software improves in processing scalability, researchers increasingly use single-cell image-based profiling to reveal important signals of phenotypic heterogeneity. Therefore, this evolution of image-based profiling toward single cells compels single-cell QC standards to ensure that observed morphology differences are driven by biology and not technical interference. We address these challenges with coSMicQC (Single cell Morphology Quality Control), a reproducible Python package with comprehensive tutorials that supports systematic filtering of low-quality single cells. CoSMicQC integrates seamlessly into standard image-based profiling protocols, providing an interactive, Jupyter-compatible user interface to detect technical outliers and set automatic thresholds. We applied coSMicQC to multiple real-world datasets and showed that our software improves data quality, detects mycoplasma contamination, and boosts phenotype prediction. When applied to a large-scale drug screening dataset, coSMicQC rescued lead compounds that would have been missed. Overall, coSMicQC is a reliable and scalable method that removes technical outliers to reduce noise and improve image-based profiling insights.
- Open Access
Scalable data harmonization for single-cell image-based profiling with CytoTable
Summary: High-content imaging (HCI) involves the automated acquisition and quantitative analysis of cell phenotypes from microscopy images. These studies often rely on screening, which can involve thousands of chemical or genetic perturbations that produce terabytes of microscopy data. To extract meaningful biological insights, this data must be processed into quantitative features through a technique known as image-based profiling. A major analytical bottleneck is curating the high-dimensional, single-cell data derived from varied image analysis tools. These datasets suffer from inconsistent schemas, inefficient file formats, and undocumented ontological relationships. These challenges reduce reproducibility and slow progress in downstream applications. To solve these issues, we introduce CytoTable 1 , a software package for harmonizing single-cell image-based profiling. CytoTable enables modular, portable, and cross-language data integration through a robust, reproducible, and scalable engine that harmonizes single-cell readouts from multiple image analysis tools, preparing for feature integration with software in the Cytomining ecosystem such as Pycytominer. 2
Open AccessScalable data harmonization for single-cell image-based profiling with CytoTable
Summary: High-content imaging (HCI) involves the automated acquisition and quantitative analysis of cell phenotypes from microscopy images. These studies often rely on screening, which can involve thousands of chemical or genetic perturbations that produce terabytes of microscopy data. To extract meaningful biological insights, this data must be processed into quantitative features through a technique known as image-based profiling. A major analytical bottleneck is curating the high-dimensional, single-cell data derived from varied image analysis tools. These datasets suffer from inconsistent schemas, inefficient file formats, and undocumented ontological relationships. These challenges reduce reproducibility and slow progress in downstream applications. To solve these issues, we introduce CytoTable 1 , a software package for harmonizing single-cell image-based profiling. CytoTable enables modular, portable, and cross-language data integration through a robust, reproducible, and scalable engine that harmonizes single-cell readouts from multiple image analysis tools, preparing for feature integration with software in the Cytomining ecosystem such as Pycytominer. 2
- 22 April 2025
- Published by Wolters Kluwer Health in Circulation
- Vol. 151 (16) , 1207-1210
Cell Painting and Machine Learning Distinguish Fibroblasts From Nonfailing and Failing Human Hearts
- 22 April 2025
- Published by Wolters Kluwer Health in Circulation
- Vol. 151 (16) , 1207-1210
Cell Painting and Machine Learning Distinguish Fibroblasts From Nonfailing and Failing Human Hearts
- Open Access
High-content microscopy and machine learning characterize a cell morphology signature of NF1 genotype in Schwann cells
Neurofibromatosis type 1 (NF1) is a multi-system, autosomal dominant genetic disorder driven by the systemic loss of the NF1 protein neurofibromin. Loss of neurofibromin in Schwann cells is particularly detrimental, as the acquisition of a ‘second-hit’ (e.g., complete loss of NF1 ) can lead to the development of plexiform neurofibromas (pNF). pNFs are painful, disfiguring tumors with an approximately 1 in 5 chance of sarcoma transition. Selumetinib and mirdametinib are currently the only medicines approved by the U.S. Food and Drug Administration (FDA) for the treatment of pNFs. This motivates the need to develop new therapies, either derived to treat NF1 haploinsufficiency or complete loss of NF1 function. To identify new therapies, we need to understand the impact neurofibromin has on Schwann cells. Here, we aimed to characterize differences in high-content microscopy in neurofibromin-deficient Schwann cells. We applied a fluorescence microscopy assay (called Cell Painting) to an isogenic pair of Schwann cell lines (derived from ipn02.3 2λ), one of wildtype genotype ( NF1 +/+ ) and one of NF1 null genotype ( NF1 -/- ). We modified the canonical Cell Painting assay to mark four organelles/subcellular compartments: nuclei, endoplasmic reticulum, mitochondria, and F-actin. We utilized CellProfiler to perform quality control, illumination correction, segmentation, and cell morphology feature extraction. We segmented 20,680 NF1 wildtype and null cells, measured 894 significant cell morphology features representing various organelle shapes and intensity patterns, and trained a logistic regression machine learning model to predict the NF1 genotype of single Schwann cells. The machine learning model had high performance, with training and testing data yielding a balanced accuracy of 0.85 and 0.80, respectively. However, when applied to a new pair of Schwann cells, the model’s balanced accuracy dropped to 0.5, which is no better than random chance. This performance decline appears to result from morphology differences introduced by non-biological factors (cloning procedures, origin of parental cell line, and CRISPR procedures) of the second cell line pair. We plan to improve upon this preliminary model by refining the NF1 morphology signature using a broader panel of Schwann cell lines. Our goal is to apply this enhanced signature in large-scale drug screens of NF1 -deficient cells to identify candidate therapeutic agents that specifically reverse the disease-associated morphology. Ultimately, we aim to identify agents that restore NF1 patient-derived Schwann cells to a phenotype resembling the NF1 wild-type and healthier state.
Open AccessHigh-content microscopy and machine learning characterize a cell morphology signature of NF1 genotype in Schwann cells
Neurofibromatosis type 1 (NF1) is a multi-system, autosomal dominant genetic disorder driven by the systemic loss of the NF1 protein neurofibromin. Loss of neurofibromin in Schwann cells is particularly detrimental, as the acquisition of a ‘second-hit’ (e.g., complete loss of NF1 ) can lead to the development of plexiform neurofibromas (pNF). pNFs are painful, disfiguring tumors with an approximately 1 in 5 chance of sarcoma transition. Selumetinib and mirdametinib are currently the only medicines approved by the U.S. Food and Drug Administration (FDA) for the treatment of pNFs. This motivates the need to develop new therapies, either derived to treat NF1 haploinsufficiency or complete loss of NF1 function. To identify new therapies, we need to understand the impact neurofibromin has on Schwann cells. Here, we aimed to characterize differences in high-content microscopy in neurofibromin-deficient Schwann cells. We applied a fluorescence microscopy assay (called Cell Painting) to an isogenic pair of Schwann cell lines (derived from ipn02.3 2λ), one of wildtype genotype ( NF1 +/+ ) and one of NF1 null genotype ( NF1 -/- ). We modified the canonical Cell Painting assay to mark four organelles/subcellular compartments: nuclei, endoplasmic reticulum, mitochondria, and F-actin. We utilized CellProfiler to perform quality control, illumination correction, segmentation, and cell morphology feature extraction. We segmented 20,680 NF1 wildtype and null cells, measured 894 significant cell morphology features representing various organelle shapes and intensity patterns, and trained a logistic regression machine learning model to predict the NF1 genotype of single Schwann cells. The machine learning model had high performance, with training and testing data yielding a balanced accuracy of 0.85 and 0.80, respectively. However, when applied to a new pair of Schwann cells, the model’s balanced accuracy dropped to 0.5, which is no better than random chance. This performance decline appears to result from morphology differences introduced by non-biological factors (cloning procedures, origin of parental cell line, and CRISPR procedures) of the second cell line pair. We plan to improve upon this preliminary model by refining the NF1 morphology signature using a broader panel of Schwann cell lines. Our goal is to apply this enhanced signature in large-scale drug screens of NF1 -deficient cells to identify candidate therapeutic agents that specifically reverse the disease-associated morphology. Ultimately, we aim to identify agents that restore NF1 patient-derived Schwann cells to a phenotype resembling the NF1 wild-type and healthier state.
- Open Access
A morphology and secretome map of pyroptosis
Pyroptosis represents one type of Programmed Cell Death (PCD). It is a form of inflammatory cell death that is canonically defined by caspase-1 cleavage and Gasdermin-mediated membrane pore formation. Caspase-1 initiates the inflammatory response (through IL-1β processing), and the N-terminal cleaved fragment of Gasdermin D polymerizes at the cell periphery forming pores to secrete pro-inflammatory markers. Cell morphology also changes in pyroptosis, with nuclear condensation and membrane rupture. However, recent research challenges canon, revealing a more complex secretome and morphological response in pyroptosis, including overlapping molecular characterization with other forms of cell death, such as apoptosis. Here, we take a multimodal, systems biology approach to characterize pyroptosis. We treated human Peripheral Blood Mononuclear Cells (PBMCs) with 36 different combinations of stimuli to induce pyroptosis or apoptosis. We applied both secretome profiling (nELISA) and high-content fluorescence microscopy (Cell Painting). To differentiate apoptotic, pyroptotic and control cells, we used canonical secretome markers and modified our Cell Painting assay to mark the N-terminus of Gasdermin-D. We trained hundreds of machine learning (ML) models to reveal intricate morphology signatures of pyroptosis that implicate changes across many different organelles and predict levels of many pro-inflammatory markers. Overall, our analysis provides a detailed map of pyroptosis which includes overlapping and distinct connections with apoptosis revealed through a mechanistic link between cell morphology and cell secretome.
Open AccessA morphology and secretome map of pyroptosis
Pyroptosis represents one type of Programmed Cell Death (PCD). It is a form of inflammatory cell death that is canonically defined by caspase-1 cleavage and Gasdermin-mediated membrane pore formation. Caspase-1 initiates the inflammatory response (through IL-1β processing), and the N-terminal cleaved fragment of Gasdermin D polymerizes at the cell periphery forming pores to secrete pro-inflammatory markers. Cell morphology also changes in pyroptosis, with nuclear condensation and membrane rupture. However, recent research challenges canon, revealing a more complex secretome and morphological response in pyroptosis, including overlapping molecular characterization with other forms of cell death, such as apoptosis. Here, we take a multimodal, systems biology approach to characterize pyroptosis. We treated human Peripheral Blood Mononuclear Cells (PBMCs) with 36 different combinations of stimuli to induce pyroptosis or apoptosis. We applied both secretome profiling (nELISA) and high-content fluorescence microscopy (Cell Painting). To differentiate apoptotic, pyroptotic and control cells, we used canonical secretome markers and modified our Cell Painting assay to mark the N-terminus of Gasdermin-D. We trained hundreds of machine learning (ML) models to reveal intricate morphology signatures of pyroptosis that implicate changes across many different organelles and predict levels of many pro-inflammatory markers. Overall, our analysis provides a detailed map of pyroptosis which includes overlapping and distinct connections with apoptosis revealed through a mechanistic link between cell morphology and cell secretome.
- Open Access
Toward generalizable phenotype prediction from single-cell morphology representations
Functional cell processes (e.g., molecular signaling, response to environmental stimuli, mitosis, etc.) impact cell phenotypes, which scientists can easily and robustly measure with cell morphology. However, linking these morphology measurements with phenotypes remains challenging because biologically interpretable phenotypes require manually annotated labels. Automatic phenotype annotation from cell morphology would link biological processes with their phenotypic outcomes and deepen understanding of cell function. We propose that nuclear morphology can be a predictive marker for cell phenotypes that is generalizable across cell types. Nucleus morphology is commonly and easily accessible with microscopy, but annotating specific phenotypic information requires labels. Therefore, we reanalyzed a pre-labeled, publicly-available nucleus microscopy dataset from the MitoCheck consortium to predict single-cell phenotypes. We extracted single-cell morphology features using CellProfiler and DeepProfiler, which provide fast, robust, and generalizable data processing pipelines. We trained multinomial, multi-class elastic net logistic regression models to classify nuclei into one of 15 phenotypes such as ‘Anaphase,’ ‘Apoptosis’, and ‘Binuclear’. In a held-out test set, we observed an overall F1 score of 0.84, where individual phenotype scores ranged from 0.64 (indicating moderate performance) to 0.99 (indicating high performance). Notably, phenotypes such as ‘Elongated’, ‘Metaphase’, and ‘Apoptosis’ showed high performance. While CellProfiler and DeepProfiler morphology features were generally equally effective, combining feature spaces yielded the best results for 9 of the 15 phenotypes. However, leave-one-image-out (LOIO) cross-validation analysis showed a significant performance decline, indicating our model could not reliably predict phenotype in new single images. Poor performance, which we show was unrelated to factors like illumination correction or model selection, limits generalizability to new datasets and highlights the challenges of morphology to phenotype annotation. Nevertheless, we modified and applied our approach to the JUMP Cell Painting pilot data. Our modified approach improved dataset alignment and highlighted many perturbations that are known to be associated with specific phenotypes. We propose several strategies that could pave the way for more generalizable methods in single-cell phenotype prediction, which is a step toward morphology representation ontologies that would aid in cross-dataset interpretability.
Open AccessToward generalizable phenotype prediction from single-cell morphology representations
Functional cell processes (e.g., molecular signaling, response to environmental stimuli, mitosis, etc.) impact cell phenotypes, which scientists can easily and robustly measure with cell morphology. However, linking these morphology measurements with phenotypes remains challenging because biologically interpretable phenotypes require manually annotated labels. Automatic phenotype annotation from cell morphology would link biological processes with their phenotypic outcomes and deepen understanding of cell function. We propose that nuclear morphology can be a predictive marker for cell phenotypes that is generalizable across cell types. Nucleus morphology is commonly and easily accessible with microscopy, but annotating specific phenotypic information requires labels. Therefore, we reanalyzed a pre-labeled, publicly-available nucleus microscopy dataset from the MitoCheck consortium to predict single-cell phenotypes. We extracted single-cell morphology features using CellProfiler and DeepProfiler, which provide fast, robust, and generalizable data processing pipelines. We trained multinomial, multi-class elastic net logistic regression models to classify nuclei into one of 15 phenotypes such as ‘Anaphase,’ ‘Apoptosis’, and ‘Binuclear’. In a held-out test set, we observed an overall F1 score of 0.84, where individual phenotype scores ranged from 0.64 (indicating moderate performance) to 0.99 (indicating high performance). Notably, phenotypes such as ‘Elongated’, ‘Metaphase’, and ‘Apoptosis’ showed high performance. While CellProfiler and DeepProfiler morphology features were generally equally effective, combining feature spaces yielded the best results for 9 of the 15 phenotypes. However, leave-one-image-out (LOIO) cross-validation analysis showed a significant performance decline, indicating our model could not reliably predict phenotype in new single images. Poor performance, which we show was unrelated to factors like illumination correction or model selection, limits generalizability to new datasets and highlights the challenges of morphology to phenotype annotation. Nevertheless, we modified and applied our approach to the JUMP Cell Painting pilot data. Our modified approach improved dataset alignment and highlighted many perturbations that are known to be associated with specific phenotypes. We propose several strategies that could pave the way for more generalizable methods in single-cell phenotype prediction, which is a step toward morphology representation ontologies that would aid in cross-dataset interpretability.